Cooperation and network

The success of the rechargeable Li-ion battery is apparent to everyone, as most people in the Western world own at least one device powered by this technology. Now, this battery type is on the verge of becoming even more relevant with the transition from vehicles using a combustion engine to the more environmentally friendly battery-driven vehicles.

The proposed project deals with high-resolution measurements of the lifetime of magnetic excitations in simple (quantum) magnets and of lattice vibrations (phonons) in the nominally well-understood simple-metal superconductors. The results will be compared with model calculations, which are density functional theory (DFT) calculations for phonons, and concepts beyond linear spin wave theory for quantum magnets. The results will be essential for the understanding of basic notions in quantum effects in magnetism, as well as in the foundations of superconductivity in simple metals.

The Nordic Neutron Scattering Program (NNSP) is an initiative launched by NordForsk on preparing the Nordic scientific communities for using the European Spallation Source (ESS), which is under construction in Lund (S). The budget of NNSP is of the order 60 million NOK, of which most will go to employ and train Ph.D. student in cross-national projects within scientific fields and methods relevant in the context of ESS.

The Committee of Nordic ART and Safety (CoNARTaS) was established five year ago and have the responsibility for the Nordic ART and Safety database including all children born after assisted reproductive technology (ART) in Finland, Norway, Sweden and Denmark since 1982.

The NORDTREAT project will build on the achievements within recent large-scale European initiatives that includes cross-disciplinary collaborations between academia, hospitals, biomedical companies and patient organisations. The overall aim is to improve Inflammatory bowel disease (IBD) patients' prognosis and quality of life by introducing a novel personalized medicine algorithm that is based on recently generated -omics data.

The aims of the ALLTogether study are to improve survival and quality of survival for children and young adults with ALL. ALL in young people has excellent outcome with >90% survival in children and about 75% in young adults. However, patients still die of diseases after relapse as a result of under-treatment.